Acticor Biotech

Paris, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

$8.7M raised

Mar 2024

Post-IPO Equity

Biopharma Biotechnology Pharmaceutical Therapeutics

Top Investors

GO CAPITAL Mirae Asset Karista Newton Biocapital UI Investissement

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Acticor Biotech

How much funding has Acticor Biotech raised?

Acticor Biotech has raised $8.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2024.

Who are Acticor Biotech's investors?

Acticor Biotech's investors include GO CAPITAL, Mirae Asset, Karista, Newton Biocapital, UI Investissement.

Where is Acticor Biotech headquartered?

Acticor Biotech is headquartered in Paris, France.

What does Acticor Biotech do?

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

What stage is Acticor Biotech at?

Acticor Biotech is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 15, 2024.

MLA

"Acticor Biotech — Funding & Investors." VCBacked, March 15, 2024, https://www.vcbacked.co/company/acticor-biotech. Accessed July 4, 2026.

APA

VCBacked. (2024). Acticor Biotech — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/acticor-biotech

Wikipedia (cite web)

{{cite web |title=Acticor Biotech — Funding & Investors |url=https://www.vcbacked.co/company/acticor-biotech |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 15, 2024.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.